Willingness to volunteer in a phase I/II HIV vaccine trial: A study among police officers in Dar Es Salaam, Tanzania

Global Health Action

Volumn 2, Issue 1, 2009, Pages

  Tarimo, Edith A M ^a,b   Thorson, Anna ^a   Bakari, Muhammad ^b   Mwami, Joachim ^c   Sandström, Eric ^a   Kulane, Asli ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF DAR ES SALAAM   (Tanzania)

Author keywords

HIV vaccine trials; Police officers; Tanzania; Willingness

Indexed keywords

EID: 77953810804     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v2i0.1953     Document Type: Article

References (29)

1. Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA 2006; 296: 855-8.
2. UNAIDS. Sub-Saharan African AIDS epidemic update, regional summary. Geneva: UNAIDS and WHO; 2008.
3. Msisha WM, Kapiga SH, Earls FJ, Subramanian SV. Place matters: multilevel investigation of HIV distribution in Tanzania. AIDS 2008; 22: 741-8.
4. TACAIDS. Follow-up to the declaration of commitment (UNGASS), indicators country report template: reporting period Jan 2003-Dec 2005. Dar es Salaam, Tanzania; 2006.
5. Somi GR, Matee MI, Swai RO, Lyamuya EF, Killewo J, Kwesigabo G, et al. Estimating and projecting HIV prevalence and AIDS deaths in Tanzania using antenatal surveillance data. BMC Public Health 2006; 6: 120-6.
6. THIS 2003-04. Tanzania HIV/AIDS Indicator Survey (THIS) 2003-04. Dar es Salaam: Tanzania Commission for AIDS (TACAIDS); 2005.
7. TACAIDS. UNGASS Country Progress Report, Tanzania mainland. Dar es Salaam, Tanzania; 2008.
8. Mmbaga EJ, Hussain A, Leyna GH, Holm-Hansen C, Mnyika KS, Sam NE, et al. Trends in HIV-1 prevalence and risk behaviours over 15 years in a rural population in Kilimanjaro region of Tanzania. AIDS Res Ther 2007; 4: 23-33.
9. Mmbaga EJ, Hussain A, Leyna GH, Mnyika KS, Sam NE, Klepp KI. Prevalence and risk factors for HIV-1 infection in rural Kilimanjaro region of Tanzania: implications for prevention and treatment. BMC Public Health 2007; 7: 58-67.
10. Msuya SE, Mbizvo E, Hussain A, Uriyo J, Sam NE, Stray-Pedersen B. HIV among pregnant women in Moshi Tanzania: the role of sexual behavior, male partner characteristics and sexually transmitted infections. AIDS Res Ther 2006; 3: 27-37.
11. Yahya-Malima KI, Olsen BE, Matee MI, Fylkesnes K. The silent HIV epidemic among pregnant women within rural Northern Tanzania. BMC Public Health 2006; 6: 109-18.
12. Esparza J, Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? Lancet 2000; 355: 2061-6.
13. Esparza J. An HIV vaccine: how and when? Bull World Health Organ 2001; 79: 1133-7.
14. Dhalla S, Woods R, Strathdee SA, Patrick DM, Hogg RS. HIV vaccine preparedness studies in the Organization for Economic Co-operation and Development (OECD) countries. AIDS Care 2007; 19: 1118-27.
15. Jenkins RA, Torugsa K, Markowitz LE, Mason CJ, Jamroentana V, Brown AE, et al. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sex Transm Infect 2000; 76: 386-92.
16. Kiwanuka N, Robb M, Kigozi G, Birx D, Philips J, Wabwire-Mangen F, et al. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda. J Acquir Immune Defic Syndr 2004; 36: 721-5.
17. Starace F, Wagner TM, Luzi AM, Cafaro L, Gallo P, Rezza G. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care 2006; 18: 66-72.
18. Van de Ven P, Mao L, Crawford J, Prestage G, Grulich A, Kaldor J, et al. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. Int J STD AIDS 2005; 16: 314-7.
19. Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, et al. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005; 39: 359-64.
20. Suhadev M, Nyamathi AM, Swaminathan S, Venkatesan P, Raja Sakthivel M, Shenbagavalli R, et al. A pilot study on willingness to participate in future preventive HIV vaccine trials. Indian J Med Res 2006; 124: 631-40.
21. McGrath JW, George K, Svilar G, Ihler E, Mafigiri D, Kabugo M, et al. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr 2001; 27: 381-8.
22. Bakari M, Lyamuya E, Mugusi F, Aris E, Chale S, Magao P, et al. The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials. AIDS 2000; 14: 313-20.
23. Crosby RA, Holtgrave DR. Will sexual risk behaviour increase after being vaccinated for AIDS? Int J STD AIDS 2006; 17: 180-4.
24. Kafaar Z, Kagee A, Lesch A, Swartz L. Is participation in HIV vaccine trials a health promoting behaviour? AIDS Care 2007; 19: 1307-9.
25. Allen M, Israel H, Rybczyk K, Pugliese MA, Loughran K, Wagner L, et al. Trial-related discrimination in HIV vaccine clinical trials. AIDS Res Hum Retroviruses 2001; 17: 667-74.
26. Barrington C, Moreno L, Kerrigan D. Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic. AIDS Care 2007; 19: 871-7.
27. Lesch A, Kafaar Z, Swartz L. Community members' perceptions of enablers and inhibitors to participation in HIV vaccine trials. S Afr JPsychol 2006; 36: 734-61.
28. McCluskey MM, Alexander SB, Larkin BD, Murguia M, Wakefield S. An HIV vaccine: as we build it, will they come? Health Aff (Project Hope) 2005; 24: 643-51.
29. Rudy ET, Newman PA, Duan N, Kelly EM, Roberts KJ, Seiden DS. HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake. AIDS Educ Prev 2005; 17: 253-67.